Related references
Note: Only part of the references are listed.AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer
Hiroyuki Motoshima et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Activation of protein kinase Cζ by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells
ZL Xie et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase
BJ Davis et al.
DIABETES (2006)
The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases
RL Hurley et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sildenafil inhibits the formation of superoxide and the expression of gp47phox NAD[P]H oxidase induced by the thromboxane A2 mimetic, U46619, in corpus cavernosal smooth muscle cells
AJ Koupparis et al.
BJU INTERNATIONAL (2005)
Ca2+/calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells
A Woods et al.
CELL METABOLISM (2005)
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase
SA Hawley et al.
CELL METABOLISM (2005)
New roles for the LKB1→AMPK pathway
DG Hardie
CURRENT OPINION IN CELL BIOLOGY (2005)
Activation of AMP-activated protein kinase (AMPK) inhibits protein synthesis: a potential strategy to prevent the development of cardiac hypertrophy
AYM Chan et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2005)
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress
RJ Shaw et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus
MH Zou et al.
ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH (2004)
Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2α, prostaglandin F2α, cytokines and endotoxin in the pig pulmonary artery
S Muzaffar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
AYM Chan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation
D Nagata et al.
CIRCULATION (2004)
Possible involvement of the α1 isoform of 5′ AMP-activated protein kinase in oxidative stress-stimulated glucose transport in skeletal muscle
T Toyoda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
AMP-activated protein kinase: A key system mediating metabolic responses to exercise
DG Hardie
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2004)
The AMP-activated protein kinase pathway - new players upstream and downstream
DG Hardie
JOURNAL OF CELL SCIENCE (2004)
Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo -: Role of mitochondrial reactive nitrogen species (Publication with Expression of Concern. See vol. 294, pg. 10024, 2019) (Withdrawn Publication. See vol. 294, pg. 13525, 2019)
MH Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
A Woods et al.
CURRENT BIOLOGY (2003)
Activation of 5′-AMP-activated kinase is mediated through c-Src and phosphoinositide 3-kinase activity during hypoxia-reoxygenation of bovine aortic endothelial cells -: Role of peroxynitrite (Publication with Expression of Concern. See vol. 294, pg. 10023, 2019) (Withdrawn Publication. See vol. 294, pg. 18016, 2019)
MH Zou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Oxidative stress and endothelial nitric oxide bioactivity
SR Thomas et al.
ANTIOXIDANTS & REDOX SIGNALING (2003)
Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat
EA Ellis et al.
NITRIC OXIDE-BIOLOGY AND CHEMISTRY (2002)
Thromboxane receptor density is increased in human cardiovascular disease with evidence for inhibition at therapeutic concentrations by the AT1 receptor antagonist losartan
SD Katugampola et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
The regulation of AMP-activated protein kinase by H2O2.
SL Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Thromboxane A2 receptor mediated activation of the mitogen activated protein kinase cascades in human uterine smooth muscle cells
SM Miggin et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2001)
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
AS Marsin et al.
CURRENT BIOLOGY (2000)
New trends in thromboxane and prostacyclin modulators
JM Dogné et al.
CURRENT MEDICINAL CHEMISTRY (2000)